Year: 2024

IRLAB’s Pioneering Phase IIb Study with Pirepemat – React-PD – Provides New Insights in Specific Parkinson’s Patient Population and Enables a Data Driven Prediction of Study Timelines

GOTHENBURG, SWEDEN / ACCESSWIRE / February 6, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 6, 2024 - IRLAB Therapeutics...

Iodine Software Introduces AwareUM, a New Solution That Helps Hospitals Streamline Utilization Management and Strengthen Revenue Integrity

Built on Iodine's industry-leading CognitiveML engine, AwareUM emulates clinical thinking to improve productivity and meet medical necessity requirementsAUSTIN, TX /...

Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics’ AI-Driven Epigenetic-Genetic Heart Disease Tests

resTOR to be the first longevity clinic nationwide to offer the Company's blood-based epigenetic-genetic cardiovascular disease testsCHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings,...

RingCentral Modernizes Patient Care Communications for Healthcare Organizations With New EHR Integrations and Generative AI

BELMONT, Calif.--(BUSINESS WIRE)--RingCentral, Inc. (NYSE: RNG), a leading provider of AI-first global enterprise cloud communications, video, webinars, hybrid events, and...

error: Content is protected !!